PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsleft ventricular dysfunction
MeSH D018487 - left ventricular dysfunction
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D018754:Ventricular dysfunction
3 Companies
1 Drug
$
Success rate
D018487: 
Left ventricular dysfunction
92 Companies
28 Drugs
$
Success rate
D054549:Takotsubo cardiomyopathy
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
33%
3/9
Phase 3
61%
17/28
Approved: 17Overall Success rate: 20%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Hydrochlorothiazide
Allergan
Amlodipine besylate,
Hydrochlorothiazide,
Ramipril,
Valsartan
AstraZeneca
Enalapril,
Felodipine,
Enalaprilat,
Angiotensin ii,
Alpha1-proteinase inhibitor,
Spirolactone,
Lcz696,
Sglt2,
Farxiga,
AZD1305,
Betaloc
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use